Pharmacyclics (PCYC) Get Boost Following New Executive Addition
Tweet
Share
E-mailGet Alerts PCYC Hot Sheet
Join SI Premium – FREE
Pharmacyclics, Inc. (Nasdaq: PCYC) is getting a boost Wednesday following a positive management change announced late Tuesday night.
The Company added Josh Brumm from ZELTIQ Aesthetics, Inc (Nasdaq: ZLTQ) as its new EVP of Finance. Pharmacyclics said Brumm will have global responsibility for corporate finance, accounting, investor relations and IT.
Shares of Pharmacyclics are up nearly 4 percent in morning trade.
The Company added Josh Brumm from ZELTIQ Aesthetics, Inc (Nasdaq: ZLTQ) as its new EVP of Finance. Pharmacyclics said Brumm will have global responsibility for corporate finance, accounting, investor relations and IT.
Shares of Pharmacyclics are up nearly 4 percent in morning trade.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sobi CEO Guido Oelkers to depart by end of January 2027
- Valens Semiconductor names Dean Martin to head automotive unit
- Entegris Executive Chair Loy to retire, Gentilcore named board chair
Create E-mail Alert Related Categories
Insiders' Blog, Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
